VX-770
VX10-770-013
Phase 1 small_molecule completed
Quick answer
VX-770 for In Development for Cystic Fibrosis is a Phase 1 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- In Development for Cystic Fibrosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed